Literature DB >> 3336704

Bronchogenic carcinoma metastatic to normal-sized lymph nodes: frequency and significance.

B H Gross1, G M Glazer, M B Orringer, D L Spizarny, A Flint.   

Abstract

CT staging of mediastinal lymph node metastases from bronchogenic carcinoma is a subject of considerable controversy. The frequency of metastases to normal-sized lymph nodes is a critical issue related to the sensitivity of CT. The authors prospectively examined 42 patients with bronchogenic carcinoma with CT; in 39, careful surgical-pathologic correlation of mediastinal lymph node status was possible. Only 7% had metastases limited to mediastinal lymph nodes that were normal-sized at CT. This reflected a low overall frequency of metastases to normal-sized nodes and several diagnostic factors that converted potentially false-negative studies into true-positive CT studies. In this small series, metastases to enlarged nodes were more likely to have extracapsular spread of tumor, a poor prognostic factor. Overall, the authors do not consider metastases to normal-sized mediastinal lymph nodes to be a major problem in CT staging of non-small cell lung cancer.

Entities:  

Mesh:

Year:  1988        PMID: 3336704     DOI: 10.1148/radiology.166.1.3336704

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  18 in total

1.  Requirements for clinical PET: comparisons within Europe.

Authors:  Michael Bedford; Michael N Maisey
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-02       Impact factor: 9.236

Review 2.  Evaluation of lymph node metastasis in lung cancer: who is the chief justice?

Authors:  Yang Xia; Bin Zhang; Hao Zhang; Wen Li; Ko-Pen Wang; Huahao Shen
Journal:  J Thorac Dis       Date:  2015-12       Impact factor: 2.895

3.  Role of (68)Ga-DOTATOC PET-CT in the diagnosis and staging of pancreatic neuroendocrine tumours.

Authors:  Rakesh Kumar; Punit Sharma; Pramod Garg; Sellam Karunanithi; Niraj Naswa; Raju Sharma; Sanjay Thulkar; Sneh Lata; Arun Malhotra
Journal:  Eur Radiol       Date:  2011-07-13       Impact factor: 5.315

Review 4.  Endoscopic ultrasound advances, part 1: diagnosis.

Authors:  Edward Kim; Jennifer J Telford
Journal:  Can J Gastroenterol       Date:  2009-09       Impact factor: 3.522

Review 5.  Positron emission tomography/computerized tomography in lung cancer.

Authors:  Ilgin Sahiner; Gulin Ucmak Vural
Journal:  Quant Imaging Med Surg       Date:  2014-06

6.  Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer.

Authors:  Masaya Tamura; Isao Matsumoto; Yusuke Tanaka; Daisuke Saito; Shuhei Yoshida; Munehisa Takata; Hirofumi Takemura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2019-09-18

7.  Relapse in resected lung cancer revisited: does intensified follow up really matter? A prospective study.

Authors:  Dragan Subotic; Dragan Mandaric; Gordana Radosavljevic; Jelena Stojsic; Milan Gajic; Maja Ercegovac
Journal:  World J Surg Oncol       Date:  2009-11-12       Impact factor: 2.754

Review 8.  Staging of bronchogenic carcinoma.

Authors:  S J Herman
Journal:  World J Surg       Date:  1993 Nov-Dec       Impact factor: 3.352

Review 9.  Present and future roles of FDG-PET/CT imaging in the management of lung cancer.

Authors:  Kazuhiro Kitajima; Hiroshi Doi; Tomonori Kanda; Tomohiko Yamane; Tetsuya Tsujikawa; Hayato Kaida; Yukihisa Tamaki; Kozo Kuribayashi
Journal:  Jpn J Radiol       Date:  2016-04-27       Impact factor: 2.374

Review 10.  Nodal staging.

Authors:  Skandadas Ganeshalingam; Dow-Mu Koh
Journal:  Cancer Imaging       Date:  2009-12-24       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.